Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis-Reference-Cited by-同舟云学术

Genetically engineered oncolytic adenovirus induces autophagic cell death through an E2F1-microRNA-7-epidermal growth factor receptor axis

Published:2012-04-30 Issue:12 Volume:131 Page:2939-2950
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Tazawa Hiroshi,Yano Shuya,Yoshida Ryosuke,Yamasaki Yasumoto,Sasaki Tsuyoshi,Hashimoto Yuuri,Kuroda Shinji,Ouchi Masaaki,Onishi Teppei,Uno Futoshi,Kagawa Shunsuke,Urata Yasuo,Fujiwara Toshiyoshi

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference50 articles.

1. Autophagy is activated in colorectal cancer cells and contributes to the tolerance to nutrient deprivation;Sato;Cancer Res,2007

2. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3;Azad;Autophagy,2008

3. Growth factor regulation of autophagy and cell survival in the absence of apoptosis;Lum;Cell,2005

4. Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis;Kruyt;Hum Gene Ther,2002

5. Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death;Abou;J Virol,2004

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells;PLOS ONE;2023-11-16

2. Intraperitoneal Administration of p53-armed Oncolytic Adenovirus Inhibits Peritoneal Metastasis of Diffuse-type Gastric Cancer Cells;Anticancer Research;2023-11

3. A new paradigm for epidermal growth factor receptor expression exists in PTC and NIFTP regulated by microRNAs;Frontiers in Oncology;2023-04-11

4. Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer;Molecular Therapy - Oncolytics;2022-12

5. Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction;Cancer Cell International;2022-04-29